Page 20 - Healthcare Sector

Alembic Pharmaceuticals gets USFDA nod for bipolar depression drug

Drug firm Alembic Pharmaceuticals on Friday said it has received final approval from the US health regulator for Lurasidone Hydrochloride tablets, used to treat bipolar depression. The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc. The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Lurasidone Hydrochloride tablets in the strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, Alembic Pharmaceuticals said in a regulatory filing. Quoting IQVIA data, Alembic Pharma said Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg have an estimated market size of USD 3.7 billion for the twelve months ending December 2020. Lurasidone Hydrochloride tablets are indicated for treatment of major depressive episodes associated with bipolar I disorder (bipolar depression). Alembic Pharma said it has settled the cas

Eris Lifesciences Q4 PAT up 21% YoY on strong show by superspecialty biz

Consolidated total income up 13%; robust anti-diabetic sales, new product pipeline, expanded coverage of cardiologists support better numbers

Multiples Alternate Asset Mgt-led group to buy Cadila's animal health biz

The deal is to sell one of Cadila's two businesses on a slump sale basis as a going concern, for a lump sum of Rs 2,921 cr on cash-free and debt-free basis

Telangana to deploy fresh grads to ease Covid strain on healthcare sector

With Telangana's healthcare sector grappling with mounting pressure of Covid pandemic, Chief Minister K Chandrasekhar Rao has decided to temporarily draw upon fresh medical and paramedical graduates

RBI recent measures to boost healthcare infrastructure, says ICRA

Availability of funds due to recent measures announced by the Reserve Bank of India (RBI) can result in increased capacities: ICRA

States may need Rs 30,000 cr to vaccinate 70% of those in 18-44 age group

Centre's support and private sector participation may relieve some of the load

Fiscal friction

Central govt should not leave everything to states

US respiratory portfolio to drive medium term sales growth for Cipla

In the domestic market, growth is expected to come from Covid-related drugs

Drug maker Caplin Steriles gets USFDA approval for an injection

The injection is used for short-term intravenous treatment of patients with acute decompensated heart failure

Behind low vaccine orders: Ghost of swine flu, laxity on second wave

The health ministry estimated that these two groups of workers would need about 66 million doses, taking into account wastage

Behind India's ventilator crisis: Lack of trained staff and idle units

Oxygen makers flag concern over shortage of liquid oxygen

Cyberattacks: Retail and healthcare sectors among most targeted

Organisations in the business and professional services, retail and hospitality, financial, healthcare and high technology were the top targets

Pharmaceutical industry rebounds in March at 10.3% growth: Ind-Ra

This was led by volume growth of 1.6 per cent, price growth of 5.1 per cent and products launches at 3.6 per cent

New launches to prop sales recovery as GSK Pharma gets over Zinetac pain

Near-term gains may be limited given restrictions which will impact anti-infectives portfolio

Alembic Pharma's injectables plant launch may face some delay

Company saw Form 483 with observations issued by US FDA for injectables plant in February

Cred boss, Unacademy co-founder, others back healthcare startup Onsurity

The startup which began its journey last Feb has on boarded 700 SMEs as healthcare partners

Healthcare sector expected to reach $372 billion in 2022: Niti Aayog report

Non-metros (Tier-II and III cities) are expected to recover faster than the metropolitan areas and tier-I cities

TataMD announces partnership with ADL for standardising Covid-19 test kit

TataMD CHECK follows guidelines set by India's drug regulator and ADL has used it for over 10,000 Covid-19 tests, said the Tata group's healthcare venture

Insider alleges Eli Lilly blocked her efforts to sound alarms on drug plant

Lilly is working closely with the FDA to address concerns about the factory,

Cabinet approves reserve fund to manage healthcare schemes in country

PMSSN covers any any programme to achieve India's sustainable development goals and the targets set out in the national health policy